- Report
- February 2024
- 136 Pages
Global
From €2841EUR$2,990USD£2,444GBP
- Report
- December 2018
- 259 Pages
Global
From €1306EUR$1,375USD£1,124GBP
€2613EUR$2,750USD£2,247GBP
- Report
- August 2018
- 227 Pages
Global
From €3800EUR$4,000USD£3,269GBP
- Report
- April 2020
- 261 Pages
Global
From €3325EUR$3,500USD£2,860GBP
- Report
- April 2022
- 95 Pages
Europe
From €1425EUR$1,500USD£1,226GBP
- Report
- February 2020
- 420 Pages
Global
From €3848EUR$4,050USD£3,310GBP
- Report
- May 2022
- 314 Pages
Global
From €3283EUR$3,456USD£2,824GBP
The Central Intravenous Catheter market is a subset of the Infusions and Injectables market. Central Intravenous Catheters are medical devices used to administer medications, fluids, and nutrients directly into a patient's bloodstream. These catheters are inserted into a large vein, usually in the neck, chest, or arm, and are used for short-term or long-term treatments. Central Intravenous Catheters are used in a variety of medical settings, including hospitals, clinics, and home care.
The Central Intravenous Catheter market is highly competitive, with a number of companies offering a wide range of products. Companies in the market include B. Braun, Baxter, C. R. Bard, Teleflex, Smiths Medical, and AngioDynamics. Show Less Read more
